Increased activity of the GSK-3β enzyme is a factor that manifests itself in the development of numerous disease entities such as Alzheimer’s disease, schizophrenia, diabetes and cancers. The gene discussed is GSK3B; the disease is early-onset autosomal dominant Alzheimer disease.